已收盤 11-06 16:00:00 美东时间
+7.450
+4.43%
今日重点评级关注:Citizens:维持Precigen"跑赢大市"评级,目标价从11美元升至12美元;Leerink Partners:维持Arcus Biosciences"跑赢大市"评级,目标价从46美元升至49美元
11-06 16:15
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. BMO Capital analyst Harsh Kumar initiated coverage on Astera Labs Inc (NASDAQ:ALAB) with an Outpe...
11-06 01:05
11月3日,阿利根尼(ATI)收涨5.31%,报174.38美元,成交额2.98亿美元,市值237.45亿美元。 行情数据 • 开盘价:170.66美元 • 最...
11-03 05:43
今日重点评级关注:Canaccord Genuity:维持Viking Therapeutics"买入"评级,目标价从106美元升至118美元;Canaccord Genuity:维持Aclaris Therapeutics"买入"评级,目标价从10美元升至13美元
11-02 18:53
BTIG analyst Andre Madrid maintains ATI (NYSE:ATI) with a Buy and lowers the price target from $270 to $250.
10-30 19:27
华盛资讯10月30日讯,ATI Inc公布2026财年Q3业绩,公司Q3营收14.24亿美元,同比增长26.5%,归母净利润1.90亿美元,同比增长72.5%。
10-30 02:32
华盛资讯10月29日讯,ATI Inc公布2026财年Q3业绩,公司Q3营收14.24亿美元,同比增长26.5%,归母净利润1.90亿美元,同比增长72.5%。
10-29 19:45
ATI (NYSE:ATI) raises FY2026 Adj EPS guidance from $4.90-$5.18 to $5.17-$5.23 vs $5.14 analyst estimate..
10-29 19:32
ATI (NYSE:ATI) is looking for Q4 Adj EPS of $1.51-$1.57 vs $1.54 analyst estimate..
10-29 19:32
ATI Inc. reported fiscal Q3 2026 sales of $1.42 billion, up 26% year over year, while diluted EPS rose to $1.37 from $0.78. Adjusted EBITDA increased 46% to $327.9 million and margin expanded 300 basis points to 23.0%, led by sharply higher AA&S earnings and margin. HPMC sales grew, but new-alloy production ramp costs pressured profitability. Quarterly operating cash flow declined to $154.6 million, and ATI raised the midpoint of its full-year ad
10-29 11:42